INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![GettyImages-1022854264-partner-hands-shaking-lab-coats]( "Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call")
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right CallDiscover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
![GettyImages-1165109678-handshake-partner-business-agreement]( "How Cara Therapeutics Increased Compliance And Reduced Study Team Burden")
How Cara Therapeutics Increased Compliance And Reduced Study Team BurdenDelve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.
-
![CRIO bridging the gap webinar]( "Bridging The Gap: EHR To EDC Integration In Clinical Trials")
Bridging The Gap: EHR To EDC Integration In Clinical TrialsThis distinguished panel of industry experts shares an engaging and honest discussion about the current state and future potential of EHR-to-EDC integration.
-
![GettyImages-1496098113_patient phone]( "Using eConsent Data To Populate Site And Sponsor Data Systems")
Using eConsent Data To Populate Site And Sponsor Data SystemsA top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.
-
What The Suvoda-Greenphire Merger Means For Clinical Trials2/18/2026
Simplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.
-
Why "Good Enough" Data Is Good Enough For Agentic AI3/9/2026
Overcome 'data paralysis' and learn why you don’t need perfect data to start leveraging AI and its benefits, and why starting today is much better than waiting for 'perfect.'
-
4 New Approvals In Q3 Across Gene, Cell, RNA Therapies11/13/2025
Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.
-
Accelerate Parkinson's Drug Development With Active, Passive DHT Monitoring4/15/2025
Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.
-
How Humans And AI Collaborate To Improve Quality, Speed, And Agility In Study Build6/22/2026
Learn how combining human expertise with AI can improve speed, consistency, and oversight while identifying issues earlier and supporting higher-quality clinical trial execution.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![GettyImages-1372091146 patient ipad]( "Improving The Patient Experience With Total Consent")
Increased outreach, heightened involvement, superior quality. Tour this comprehensive consent management solution that enhances participant access and improves the overall patient experience.
-
![trialscope1]( "Trial Results Summaries")
TrialScope’s Trial Results Summaries (TrialSummaries.com) provides an unbiased and nonpromotional portal for sponsors to share plain-language summaries (PLS) with participants and the public
-
![trial-CRO-meeting-GettyImages-1206260023]( "FSP: Global Support To Fit Clinical Trial Management Needs")
Worldwide Flex provides flexible, scalable solutions and services to enhance our clients’ outsourcing needs. We are a specialized provider of multi-therapeutic functional solutions delivered by our experts.
-
![GettyImages-94098912 trial doses]( "Precision In Every Dose, Confidence In Every Time Point")
Precision in every dose, confidence in every time point.
Guided dose workflows. Captured. Verifiable. Audit-ready by default.
-
![GettyImages-1059548518 global conntection]( "Create, Collaborate, & Solve With A Global Innovators")
Learn how academic researchers, analytic companies, sensor and connected device organizations, sponsors, and CROs can unleash the potential of human-data connections.
